Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Genital Herpes Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for genital herpes has witnessed considerable expansion in recent times. It’s projected to increase from $2.19 billion in 2024 to $2.34 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The factors that contributed to the growth during the historic period include the rise in knowledge and diagnosis, advancements in therapeutics, enhanced healthcare access, public health initiatives and socio-demographic influences.
In the coming years, strong expansion is anticipated in the genital herpes market, which is predicted to reach a size of$2.99 billion by 2029,” boasting a compound annual growth rate (CAGR) of 6.4%. Numerous factors contribute to this expected growth during the forecast period, such as increased knowledge and educational efforts, enhancements in treatments and vaccinations, an upswing in occurrence rates, the advent of digital health tech, broader healthcare access, and proliferating STI awareness initiatives. Furthermore, the forecast period will show major trends like the embrace of telemedicine, cutting-edge developments in antiviral therapy, extensive research and development in the vaccine field, an extended reach of healthcare services, amplified public education drives, and the application of artificial intelligence and data analysis.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Genital Herpes Market?
The growth of the genital herpes market is predicted to be fueled by an increasing emphasis on sexual health. This surge in attention towards sexual health is attributed to the growing acknowledgement of its crucial part in overall wellbeing and life quality. The main uses of sexual health services for genital herpes include diagnosis, treatment, counseling, and continuous management to assist people in handling outbreaks, inhibiting transmission, and tackling emotional and relationship issues tied to the condition. As per the Local Government Association, a national membership body based in the UK, there was an increase in the demand for sexual health services in January 2024, with almost 4.5 million consultations conducted in 2022, which is a 33% increase. Additionally, there was considerable activity in diagnostic testing, with 2.2 million tests carried out in 2022, a 13% increase compared to 2021. Thus, the heightened attention towards sexual health is projected to stimulate the growth of the genital herpes market.
Which Key Market Segments Comprise the Genital Herpes Market and Drive Its Revenue Growth?
The genital herpesmarket covered in this report is segmented –
1) By Type: Diagnosis; Treatment
2) By Route Of Administration: Oral; Injectable; Topical
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channel
Subsegments:
1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests; Viral Culture Tests; Blood Antibody Tests (Serology); Antigen Detection Tests; Point-Of-Care Rapid Tests
2) By Treatment: Antiviral Medications; Acyclovir; Valacyclovir; Famciclovir; Topical Treatments; Acyclovir Cream; Docosanol Cream; Preventive Therapies; Suppressive Therapy; Prophylactic Vaccines (Under Development); Pain Management Medications; Analgesics; Topical Anesthetics
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=17161&type=smp
Which Areas Are Leading Regions in the Genital Herpes Market Expansion Across the Globe?
North America was the largest region in the genital herpes market in 2024. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theGenital Herpes Market Over the Coming Years?
The genital herpes market is witnessing active participation from major companies through strategic partnerships aimed at boosting technological capabilities and expanding their market presence. A strategic partnership is essentially a collaborative effort between two or more organizations, pooling their resources, expertise, and energy to realize shared ambitions or goals. For example, in June 2022, Eurocine Vaccines AB, a company based in Sweden that specializes in treatments and products for herpes, declared its research and collaboration agreement with Redbiotec AG, a Swiss biotech company. The agreement offers global exclusivity rights for the development, manufacturing, and marketing of vaccine candidates that target the Herpes Simplex Virus Type 2 (HSV-2). It includes both mRNA and protein-based technologies along with related documents and patents pertinent to the HSV-2 niche. Eurocine Vaccines has committed to supervising and funding all aspects associated with the development, manufacturing, and marketing until a subsequent out-licensing agreement with another party is reached.
View the full report here:
https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report
How Is the Genital Herpes Market Conceptually Defined?
Genital herpes refers to a sexually transmitted infection (STI) caused primarily by the herpes simplex virus type 2 (HSV-2) or, less commonly, by the herpes simplex virus type 1 (HSV-1). It typically manifests as sores or blisters on the genital area, buttocks, or anal region. Genital herpes is transmitted through sexual contact with an infected person and can be managed with antiviral medications to reduce symptoms and prevent transmission to sexual partners.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17161
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model